Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday

Published 08/11/2022, 16:30
Updated 08/11/2022, 17:40
© Reuters.  Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session.

  • NanoString Technologies, Inc. (NASDAQ: NSTG) shares tumbled 47.5% to $4.84 after the company reported worse-than-expected Q3 results.
  • Bioventus Inc(NASDAQ: BVS) fell 45.1% to $3.8750 after the company reported downbeat Q3 results and lowered FY22 guidance.
  • R1 RCM Inc. (NASDAQ: RCM) dropped 44.2% to $8.23 after the company reported worse-than-expected Q3 EPS and sales results and cut FY22 revenue guidance below estimates.
  • Unisys Corporation (NYSE: UIS) fell 41.2% to $5.27 following downbeat quarterly sales.
  • The Pennant Group, Inc. (NASDAQ: PNTG) fell 27.2% to $9.87 following downbeat quarterly earnings.
  • Clarus Corporation (NASDAQ: CLAR) dropped 24.9% to $8.27 after the company reported worse-than-expected Q3 results and issued FY22 guidance below estimates.
  • Tripadvisor, Inc. (NASDAQ: TRIP) shares fell 21.8% to $18.61 after the company reported worse-than-expected Q3 EPS results.
  • Lyft (NASDAQ:LYFT), Inc. (NASDAQ: LYFT) shares fell 20.2% to $11.29 after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates. Evercore ISI Group downgraded Lyft from Outperform to In-Line and lowered the price target from $41 to $18.
  • Akoya Biosciences, Inc. (NASDAQ: AKYA) fell 18.3% to $10.63 as the company posted a wider-than-expected quarterly loss.
  • MeridianLink, Inc. (NYSE: MLNK) fell 17.9% to $13.24 after reporting a loss for the tird quarter.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) dipped 17.8% to $2.9199 following Q3 loss.
  • Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) dropped 17.8% to $4.61 after the company reported Q3 financial results.
  • MicroStrategy Incorporated (NASDAQ: MSTR) dropped 14.5% to $228.00 in sympathy with the price of Bitcoin and Ethereum.
  • Silvergate Capital Corporation (NYSE: SI) declined 14.4% to $43.59. Silvergate announced changes to its executive team.
  • Perrigo Company plc (NYSE: PRGO) dropped 14.1% to $33.75 as the company lowered FY22 profit forecast.
  • Lumentum Holdings Inc. (NASDAQ: LITE) fell 13.8% to $60.62 after the company issued Q3 EPS and sales guidance below estimates.
  • Take-Two (NASDAQ:TTWO) Interactive Software, Inc. (NASDAQ: TTWO) fell 12.2% to $95.13 after the company reported worse-than-expected Q2 results and issued weak FY23 guidance.
  • SI-BONE, Inc. (NASDAQ: SIBN) dipped 12.1% to $14.73 following Q3 results.
  • FibroGen, Inc. (NASDAQ: FGEN) fell 11.8% to $14.24 following weak quarterly results.
  • Ramaco Resources, Inc. (NASDAQ: METC) shares fell 11.2% to $11.07 after the company reported worse-than-expected Q3 results.
  • Sabra Health Care REIT, Inc. (NASDAQ: SBRA) dipped 10.4% to $12.30 following Q3 results.
  • Coinbase (NASDAQ:COIN) Global, Inc. (NASDAQ: COIN) dropped 10.2% to $51.17. Crypto-related stocks dropped sharply amid marked, ongoing volatility in the broader crypto space amid reports of a possible bankruptcy of popular cryptocurrency exchange FTX.
  • James Hardie Industries plc (NYSE: JHX) fell 9.4% to $19.33 following Q2 results.
  • ShockWave Medical, Inc. (NASDAQ: SWAV) declined 9.2% to $251.84 following Q3 results.
  • Aurora Innovation, Inc. (NASDAQ: AUR) dropped 8.4% to $1.6850.
  • DigitalOcean Holdings, Inc. (NASDAQ: DOCN) fell 6.6% to $27.46 after the company issued a weak forecast for the fourth quarter.
  • Robinhood (NASDAQ:HOOD) Markets, Inc. (NASDAQ: HOOD) dropped 6.3% to $11.27. Crypto-related stocks dropped amid marked, ongoing volatility in the broader crypto space amid reports of a possible bankruptcy of popular cryptocurrency exchange FTX.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.